← Oncology Approval Tracker

FDA DECISION ·

Scemblix

asciminib · Novartis

Traditional approvalTraditional conversionChronic myeloid leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with Philadelphia chromosome-positive chronic-phase CML after treatment with at least two tyrosine kinase inhibitors.

LAMPGEN ANALYSIS

Why it matters

The action confirms the original accelerated approval for previously treated chronic-phase disease.

What research teams should watch

Reconcile prior TKI exposure and distinguish this conversion from the separate T315I-mutated indication.

PRIMARY RECORDS

Sources